Explore Similar Technologies

Maximizing rare earth element separation with Lanmodulin protein using a novel desorption technology

LLNL inventors developed a proprietary desorption technology that enabled separation of a near-adjacent panel of REEs, marking the best separation...

Insertional gene overlap for secure genetic engineering

Genetic engineering allows insertion and propagation of a foreign genetic element in a heterologous system in a variety of applications such as the...

Method of Fabricating Silicon Carbide Nanoneedles

LLNL researchers have developed an approach to form silicon carbide (and diamond) nanoneedles using plasma etching that create micro pillars followed...

Modified cyclodextrins to counteract the effects of fentanyl and related opioids

After screening at least 50 different cyclodextrins, LLNL researchers found that the drug Subetadex shows enhanced affinities for fentanyl and its...

Protein mediated immune cell engineering

Rather than using genes carried by viruses, LLNL researchers have developed an alternative approach of delivering CAR to T-cells in form of proteins...

Automated High Throughput Screening Platform

LLNL inventors have developed a method and device for the high throughput screening of various chemical and biological entities using a novel...

Rapid Separation of Biological Particles from Complex Matrices

Contact
Reference Number
489/20
Technical Overview

Direct membrane filtration methods are often used to concentrate pathogens (viruses or bacteria). However, they may suffer from severe membrane fouling and clogging. LLNL scientists have developed a more simple and rapid method for the purification/concentration of biological particles that avoids sample clogging.

Description

This invention consists of a functionalized membrane (e.g. polyethylene glycol (PEG)) and osmosis or electric potential as a driving force. The PEG membrane provides high biological particles separation and prevents sample for clogging due to the strong hydration of functional polymers layer and their resistance to protein adsorption. The device is comprised of three chambers: 1) a feed and blood cells chamber, 2) a viral or bacterial concentration chamber, and 3) a cell waste chamber (see Figure). Each chamber is divided by membranes with different pore sizes and filled with electrolyte or draw solution to transport target solutes. The progressive filtration from the first chamber to the last chamber can be carried out by progressively reducing the size of the pore of the filtering membranes, in order to progressively filter out smaller particles. Unlike other pressure-driven membrane filtration process, this invention utilizes the osmotic pressure difference induced by the draw solution as the primary driving force to separate the particles, therefore, limiting the requirement for equipment such as vacuum pump and centrifuge. Additionally, the separated target solutes in each chamber can also be easily separated by a magnetic field if magnetic nanoparticles are used.

3D nanometer-thin membrane for ultra-fast selective mass transport
Development Status

LLNL has secured a patent (US Patent 9,861,939) covering this technology (LLNL Internal Case # IL-12916)

Advantages
  • Limiting the requirement for equipment such as vacuum pump and centrifuge
  • Separated target solutes in each chamber can also be easily separated by a magnetic field using magnetic nanoparticles
  • This device can be used by non-technical staff in a non-hospital-based setting
Potential Applications
  • A simple diagnostic platform for rapid detection of bloodstream infections
  • Polymerase chain reaction sample preparation
  • Point-of-care diagnosis
  • Viral/bacterial separation and concentration
  • Membrane filtration